MetLife, Inc. (NYSE:MET) Plans $0.55 Quarterly Dividend

MetLife, Inc. (NYSE:METGet Free Report) announced a quarterly dividend on Tuesday, October 8th, RTT News reports. Stockholders of record on Tuesday, November 5th will be given a dividend of 0.545 per share by the financial services provider on Monday, December 16th. This represents a $2.18 dividend on an annualized basis and a dividend yield of 2.78%. The ex-dividend date of this dividend is Tuesday, November 5th.

MetLife has raised its dividend by an average of 4.2% per year over the last three years and has raised its dividend every year for the last 11 years. MetLife has a dividend payout ratio of 22.4% indicating that its dividend is sufficiently covered by earnings. Analysts expect MetLife to earn $9.74 per share next year, which means the company should continue to be able to cover its $2.18 annual dividend with an expected future payout ratio of 22.4%.

MetLife Trading Up 0.0 %

NYSE MET opened at $78.43 on Monday. The company has a quick ratio of 0.16, a current ratio of 0.16 and a debt-to-equity ratio of 0.49. The stock’s 50-day simple moving average is $80.59 and its two-hundred day simple moving average is $74.92. MetLife has a twelve month low of $58.89 and a twelve month high of $86.94. The company has a market capitalization of $54.93 billion, a price-to-earnings ratio of 15.81, a PEG ratio of 0.66 and a beta of 1.05.

Analyst Upgrades and Downgrades

A number of analysts recently weighed in on the company. StockNews.com downgraded MetLife from a “buy” rating to a “hold” rating in a research report on Friday, October 4th. Morgan Stanley cut their price objective on shares of MetLife from $86.00 to $85.00 and set an “overweight” rating for the company in a research note on Monday, August 19th. Wells Fargo & Company lifted their target price on shares of MetLife from $86.00 to $92.00 and gave the stock an “overweight” rating in a research report on Thursday, October 10th. TD Cowen assumed coverage on shares of MetLife in a research report on Wednesday, October 9th. They set a “buy” rating and a $97.00 price target for the company. Finally, Barclays decreased their price objective on MetLife from $91.00 to $90.00 and set an “overweight” rating on the stock in a report on Thursday. One analyst has rated the stock with a hold rating and thirteen have assigned a buy rating to the company. Based on data from MarketBeat, the company currently has an average rating of “Moderate Buy” and an average price target of $88.38.

Check Out Our Latest Stock Analysis on MET

MetLife Company Profile

(Get Free Report)

MetLife, Inc, a financial services company, provides insurance, annuities, employee benefits, and asset management services worldwide. It operates through six segments: Retirement and Income Solutions; Group Benefits; Asia; Latin America; Europe, the Middle East and Africa; and MetLife Holdings. The company offers life, dental, group short-and long-term disability, individual disability, pet insurance, accidental death and dismemberment, vision, and accident and health coverages, as well as prepaid legal plans; administrative services-only arrangements to employers; and general and separate account, and synthetic guaranteed interest contracts, as well as private floating rate funding agreements.

Read More

Dividend History for MetLife (NYSE:MET)

Receive News & Ratings for MetLife Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MetLife and related companies with MarketBeat.com's FREE daily email newsletter.